Invention Grant
- Patent Title: Peptides that bind to the erythropoietin receptor
- Patent Title (中): 结合促红细胞生成素受体的肽
-
Application No.: US12945687Application Date: 2010-11-12
-
Publication No.: US08729030B2Publication Date: 2014-05-20
- Inventor: Christopher P. Holmes , Qun Yin , Guy Lalonde , Peter J. Schatz , David Tumelty , Palani Balu , Genet Zemede
- Applicant: Christopher P. Holmes , Qun Yin , Guy Lalonde , Peter J. Schatz , David Tumelty , Palani Balu , Genet Zemede
- Applicant Address: US CA Palo Alto
- Assignee: Affymax, Inc.
- Current Assignee: Affymax, Inc.
- Current Assignee Address: US CA Palo Alto
- Agency: Fish & Richardson P.C.
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K14/505 ; A61K38/10 ; C07K17/08

Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
Public/Granted literature
- US20110245176A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR Public/Granted day:2011-10-06
Information query